The University of Southampton
University of Southampton Institutional Repository

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
There is increasing evidence that genome-wide association (GWA) studies represent a powerful approach to the identification of genes involved in common human diseases. We describe a joint GWA study (using the Affymetrix GeneChip 500K Mapping Array Set) undertaken in the British population, which has examined similar to 2,000 individuals for each of 7 major diseases and a shared set of similar to 3,000 controls. Case-control comparisons identified 24 independent association signals at P < 5 X 10(-7): 1 in bipolar disorder, 1 in coronary artery disease, 9 in Crohn's disease, 3 in rheumatoid arthritis, 7 in type 1 diabetes and 3 in type 2 diabetes. On the basis of prior findings and replication studies thus-far completed, almost all of these signals reflect genuine susceptibility effects. We observed association at many previously identified loci, and found compelling evidence that some loci confer risk for more than one of the diseases studied. Across all diseases, we identified a large number of further signals (including 58 loci with single-point P values between 10(-5) and 5 X 10(-7)) likely to yield additional susceptibility loci. The importance of appropriately large samples was confirmed by the modest effect sizes observed at most loci identified. This study thus represents a thorough validation of the GWA approach. It has also demonstrated that careful use of a shared control group represents a safe and effective approach to GWA analyses of multiple disease phenotypes; has generated a genome-wide genotype database for future studies of common diseases in the British population; and shown that, provided individuals with non-European ancestry are excluded, the extent of population stratification in the British population is generally modest. Our findings offer new avenues for exploring the pathophysiology of these important disorders. We anticipate that our data, results and software, which will be widely available to other investigators, will provide a powerful resource for human genetics research.
rheumatoid-arthritis families, affected sibling pairs, number, population, type-1 diabetes locus, lymphoid tyrosine phosphatase, susceptibility loci, children, blood, genome-wide association, risk, disorder, identification, susceptibility, multilocus genotype data, coronary-artery-disease, bipolar disorder, disease, single-nucleotide polymorphisms, mitochondrial c-1-tetrahydrofolate synthase, inflammatory-bowel-disease, association, disorders, genetics
0028-0836
661-678
Walters, Graham R.
cd791de2-7885-493d-afa3-679de42f1e8f
Wellcome Trust Case Control Consortium, None
6fcdde03-7512-4ee1-94cb-5d09f959e203
Wellcome Trust Case Control Consortium
Walters, Graham R.
cd791de2-7885-493d-afa3-679de42f1e8f
Wellcome Trust Case Control Consortium, None
6fcdde03-7512-4ee1-94cb-5d09f959e203

Walters, Graham R. and Wellcome Trust Case Control Consortium, None , Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447 (7145), 661-678. (doi:10.1038/nature05911).

Record type: Article

Abstract

There is increasing evidence that genome-wide association (GWA) studies represent a powerful approach to the identification of genes involved in common human diseases. We describe a joint GWA study (using the Affymetrix GeneChip 500K Mapping Array Set) undertaken in the British population, which has examined similar to 2,000 individuals for each of 7 major diseases and a shared set of similar to 3,000 controls. Case-control comparisons identified 24 independent association signals at P < 5 X 10(-7): 1 in bipolar disorder, 1 in coronary artery disease, 9 in Crohn's disease, 3 in rheumatoid arthritis, 7 in type 1 diabetes and 3 in type 2 diabetes. On the basis of prior findings and replication studies thus-far completed, almost all of these signals reflect genuine susceptibility effects. We observed association at many previously identified loci, and found compelling evidence that some loci confer risk for more than one of the diseases studied. Across all diseases, we identified a large number of further signals (including 58 loci with single-point P values between 10(-5) and 5 X 10(-7)) likely to yield additional susceptibility loci. The importance of appropriately large samples was confirmed by the modest effect sizes observed at most loci identified. This study thus represents a thorough validation of the GWA approach. It has also demonstrated that careful use of a shared control group represents a safe and effective approach to GWA analyses of multiple disease phenotypes; has generated a genome-wide genotype database for future studies of common diseases in the British population; and shown that, provided individuals with non-European ancestry are excluded, the extent of population stratification in the British population is generally modest. Our findings offer new avenues for exploring the pathophysiology of these important disorders. We anticipate that our data, results and software, which will be widely available to other investigators, will provide a powerful resource for human genetics research.

This record has no associated files available for download.

More information

Published date: 7 June 2007
Keywords: rheumatoid-arthritis families, affected sibling pairs, number, population, type-1 diabetes locus, lymphoid tyrosine phosphatase, susceptibility loci, children, blood, genome-wide association, risk, disorder, identification, susceptibility, multilocus genotype data, coronary-artery-disease, bipolar disorder, disease, single-nucleotide polymorphisms, mitochondrial c-1-tetrahydrofolate synthase, inflammatory-bowel-disease, association, disorders, genetics

Identifiers

Local EPrints ID: 62342
URI: http://eprints.soton.ac.uk/id/eprint/62342
ISSN: 0028-0836
PURE UUID: fae272d8-b43d-4b43-8842-85e33238bf6a

Catalogue record

Date deposited: 10 Feb 2009
Last modified: 15 Mar 2024 11:30

Export record

Altmetrics

Contributors

Author: Graham R. Walters
Author: None Wellcome Trust Case Control Consortium
Corporate Author: Wellcome Trust Case Control Consortium

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×